SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biogen
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1686 75 0 BIIB
Emcee:  Harold Engstrom Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1211 Does anyone remember Biogen writing down the value of their equity investments Harold Engstrom-2/7/2000
1210 I heard Jim Vincent say at a conference once that he prefers the stock to remaiScott-2/5/2000
1209 No information on a split, however, it does look strong. I vote for new highs William Partmann-2/4/2000
1208 Longs, I saw a post on Yahoo finance stating that BGEN would announce a 2/1 sRichard Strutz-2/4/2000
1207 Biogen's AVONEX(R) (Interferon beta-1a) Shows A Beneficial Effect On DelayiWilliam Partmann-2/1/2000
1206 Interesting article on BGEN. ******************************* streetadvisor.comWilliam Partmann-1/31/2000
1205 BGEN will be added to the S&P 500 after the close of trading tomorrow. Withjohn yee-1/27/2000
1204 <<bgen added to S&P?>> Yes. Should be a fun day today.William Partmann-1/25/2000
1203 bgen added to S&P?dangergirl-1/25/2000
1202 BGEN was up 13.3125 pts. (see biobiznet.com) for this week (+ 16.92% for week).blackmerlin-1/23/2000
1201 08:03 ET Biogen (BGEN) 82 7/16: Merrill Lynch names the stock to their Focus OnWilliam Partmann-1/19/2000
1200 RESEARCH ALERT - Several brokerages raise Biogen NEW YORK, Jan 14 (Reuters) - SWilliam Partmann-1/14/2000
1199 RESEARCH ALERT - Biogen raised to buy CHICAGO, Jan 14 (Reuters) - ABN AMRO saidWilliam Partmann-1/14/2000
1198 Harold, we are in agreement. These analysts and the houses they work for are wWilliam Partmann-1/13/2000
1197 (Warning, this is a mild rant!) Biogen continues to grow revenues at a good clHarold Engstrom-1/13/2000
1196 CAMBRIDGE, Mass. (CBS.MW) -- Biogen posted fourth-quarter earnings slightly higWilliam Partmann-1/13/2000
1195 I'm in at 76.ALTERN8-1/12/2000
1194 Biogen Expects to Beat Estimates CAMBRIDGE, Mass. (Reuters) - Multiple sclerosiWilliam Partmann-1/12/2000
1193 RESEARCH ALERT - Biogen downgraded NEW YORK, Jan 4 (Reuters) - Salomon Smith BaWilliam Partmann-1/4/2000
1192 For those interested the data on the P II Anti-CD11a or hu1124 of Genentech is aknahow-1/4/2000
1191 BGEN: Presentation of Amevive Phase II Data; Phase III Initiated Salomon SmithWilliam Partmann-12/4/1999
1190 Thanks, interesting and looks good.aknahow-12/3/1999
1189 Company Press Release SOURCE: Biogen, Inc. Investigators Present Positive ResuWilliam Partmann-12/3/1999
1188 Psoriasis: From Gene to Clinic This is the name of the conference being held aknahow-12/2/1999
1187 Thanks George Elise is the best Biotech analyst on Wall Street. It sounds like Mark Bong-12/2/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News